Lipocine to present at the lytham partners summer 2021 investor conference

Salt lake city, june 7, 2021 /prnewswire/ -- lipocine inc. (nasdaq: lpcn), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the company will present at the lytham partners summer 2021 investor conference. the conference will be held virtually.

LPCN Ratings Summary

LPCN Quant Ranking